Hydrocodone Extended-Release Tablets and Mogamulizumab-kpkc
Determining the interaction of Hydrocodone Extended-Release Tablets and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Mogamulizumab-kpkc Intravenous
- Hydrocodone Extended-Release Tablets-Molindone
- Hydrocodone Extended-Release Tablets-Mometasone (Oral Inhalation)
- Hydrocodone Extended-Release Tablets-Mometasone and Formoterol
- Hydrocodone Extended-Release Tablets-Mometasone and formoterol Inhalation
- Hydrocodone Extended-Release Tablets-Mometasone Cream
- Mogamulizumab-kpkc-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Mogamulizumab-kpkc-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Mogamulizumab-kpkc-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Mogamulizumab-kpkc-Hydrocortisone
- Mogamulizumab-kpkc-Hydrocortisone (Systemic)
- Mogamulizumab-kpkc-Hydrocortisone 2.5%